BDBM479173 US10894789, Compound 132

SMILES C[C@@H]1CC(F)(F)CN(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nn(C)cc1-c1cccc(C)n1

InChI Key InChIKey=DSIYGNHFVBKYPE-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 479173   

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479173(US10894789, Compound 132)
Affinity DataIC50: 7nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
Go to US Patent

TargetOrexin receptor type 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM479173(US10894789, Compound 132)
Affinity DataIC50: 5.00E+3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
Go to US Patent